3-140942085-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001104647.3(SLC25A36):āc.31T>Cā(p.Phe11Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000081 in 1,468,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000073 ( 0 hom., cov: 31)
Exomes š: 0.000082 ( 0 hom. )
Consequence
SLC25A36
NM_001104647.3 missense
NM_001104647.3 missense
Scores
2
2
15
Clinical Significance
Conservation
PhyloP100: 3.60
Genes affected
SLC25A36 (HGNC:25554): (solute carrier family 25 member 36) Enables pyrimidine nucleotide transmembrane transporter activity. Involved in mitochondrial genome maintenance; pyrimidine nucleotide transport; and regulation of mitochondrial membrane potential. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.4117604).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC25A36 | NM_001104647.3 | c.31T>C | p.Phe11Leu | missense_variant | 1/7 | ENST00000324194.12 | NP_001098117.1 | |
SLC25A36 | NM_018155.3 | c.31T>C | p.Phe11Leu | missense_variant | 1/7 | NP_060625.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC25A36 | ENST00000324194.12 | c.31T>C | p.Phe11Leu | missense_variant | 1/7 | 1 | NM_001104647.3 | ENSP00000320688.6 |
Frequencies
GnomAD3 genomes AF: 0.0000731 AC: 11AN: 150426Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
11
AN:
150426
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000857 AC: 1AN: 116722Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 62248
GnomAD3 exomes
AF:
AC:
1
AN:
116722
Hom.:
AF XY:
AC XY:
0
AN XY:
62248
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000819 AC: 108AN: 1318424Hom.: 0 Cov.: 24 AF XY: 0.0000906 AC XY: 59AN XY: 651342
GnomAD4 exome
AF:
AC:
108
AN:
1318424
Hom.:
Cov.:
24
AF XY:
AC XY:
59
AN XY:
651342
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000731 AC: 11AN: 150544Hom.: 0 Cov.: 31 AF XY: 0.0000408 AC XY: 3AN XY: 73518
GnomAD4 genome
AF:
AC:
11
AN:
150544
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
73518
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2023 | The c.31T>C (p.F11L) alteration is located in exon 1 (coding exon 1) of the SLC25A36 gene. This alteration results from a T to C substitution at nucleotide position 31, causing the phenylalanine (F) at amino acid position 11 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T;T;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;N;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;N
REVEL
Uncertain
Sift
Benign
T;T;T;T
Sift4G
Benign
T;T;T;T
Polyphen
B;B;B;.
Vest4
MutPred
Gain of glycosylation at T6 (P = 0.0484);Gain of glycosylation at T6 (P = 0.0484);Gain of glycosylation at T6 (P = 0.0484);Gain of glycosylation at T6 (P = 0.0484);
MVP
MPC
0.79
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at